objective

the discovery grants program assists in:

• promoting and maintaining a diversified base of high-quality research capability in the natural sciences and engineering in canadian universities;
• fostering research excellence;
• providing a stimulating environment for research training.

description

the discovery grants program supports ongoing programs of research with long-term goals rather than a single short-term project or collection of projects. these grants recognize the creativity and innovation that are at the heart of all research advances. discovery grants are considered “grants in aid” of research, as they provide long term operating funds and can facilitate access to funding from other programs, but are not meant to support the full costs of a research program.

recipients of discovery grants are not restricted to the specific activities described in their applications, and may pursue new research interests, provided they are within nserc’s mandate. this provides researchers with the flexibility to pursue promising research avenues as they emerge and the opportunity to address higher-risk (higher reward) topics. researchers can use their grants to participate in collaborative efforts.

eureka clusters (celtic-next, eurogia, itea 3, and penta-euripides^²) have launched a common cross-domain call for proposals for joint research and development (r&d) innovative projects in artificial intelligence. participating countries include austria, belgium, canada, denmark, finland, germany, hungary, luxembourg, malta, netherlands, portugal, south korea, spain, sweden and turkey.

open to:

• small and medium-sized enterprises (sme)
• large enterprises and industries
• universities
• research organizations
• others

funding through nrc irap is only available to eligible smes. other organizations will need to secure funding from other sources or self-fund.

sectors of focus:

• artificial intelligence

deadline to submit international consortium project proposal: june 15, 2020

the specific objective of this funding opportunity is to generate research evidence using rigorous methodologies and to build relevant capacity in key research areas related to vaping in both youth and adults by:

• generating preliminary observations, data or knowledge;
• supporting projects which have the potential to generate high impact results and/or innovative research proposals; and
• facilitating consideration and application of new evidence to inform ongoing and future development of policies, practices and programs related to vaping.

this call is open to canadians, permanent residents of canada, and citizens of developing countries pursuing doctoral studies at a canadian university. awards under this call will cover the costs of field research conducted for a doctoral dissertation in one or more countries in the global south.

the specific objectives of this funding opportunity are:

• to address evidence gaps and build the evidence base for the mental health and substance use response to covid-19.
• to provide current evidence on mental health services needs, delivery and related guidelines, practice and issues, placed in the covid-19 context (e.g. effective virtual service delivery models, or other models of care).
• to provide decision makers with high quality, timely, accessible and relevant evidence that responds to a priority need in a short period of time.

in the spirit of looking ahead towards better days, the azrieli foundation is pleased to circulate the attached announcement for our request for applications (rfa): rna and the brain. we hope that you will help us distribute this information to researchers who may be interested. we are seeking proposals from researchers in the field of neuroscience and molecular biology as described in the attached. there are more details here. the due date for the letter of intent is may 15, 2020. we ask that interested applicants use our application portal which can be accessed from our website. the azrieli foundation is closely monitoring the pandemic situation and its effects on the research community and will revisit due dates and timelines as the situation progresses.  updates will be posted on the foundation’s website.

please send inquiries to science.grants@azrielifoundation.org

please distribute to faculty and postdoctoral fellows.

the call is open! mitacs elevate is now accepting proposal submissions for two years of postdoc funding valued at $60,000/year plus extensive customized professional development training ($7,500/year non-cash value).

postdocs:

• manage a long-term collaborative research project with a company or not-for-profit
• develop business-ready skills in leadership, financial literacy, management and negotiation, project management, problem solving and much more

 
key deadlines:

• june 10, 2020 — deadline to submit draft application for pre-review and (if applicable) conflict of interest declaration at 5 p.m. pt
• july 22, 2020 — deadline to submit full application at 5 p.m. pt

 
for questions or more information, please contact us at elevate@mitacs.ca.
 
mitacs recognizes that due to the pandemic and the uncertainties it’s created, you may be operating with limited ability to plan future research projects. if you feel that you cannot submit an elevate proposal at this time due to the pandemic, please reach out to us at elevate@mitacs.ca.

the fy20 defense appropriations act provides funding to the department of defense multiple sclerosis research program (msrp) to support innovative and impactful research that addresses fundamental issues and gaps in multiple sclerosis (ms).  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and development command (usamrdc).

the fy20 msrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website. 

applications submitted to the fy20 msrp must address at least one of the focus areas relevant to the award mechanism as described in the table below.

https://cdmrp.army.mil/funding/msrp

clinical trial award (new!!!) – preproposal due june 17, 2020

independent investigators at or above the level of assistant professor (or equivalent)

• pre-application submission is required; application submission is by invitation only.
• supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ms.
• funds phase 0, i or ii clinical trials relevant to ms; combinations of phases are permitted.
• funding must support a clinical trial and may not be used for preclinical studies.
• anticipated that budgets will not exceed $1.5 million in direct costs (plus indirect costs).
• period of performance not to exceed 4 years.

exploration -hypothesis development award – preproposal due june 17, 2020

established investigators: independent investigators at or above the level of assistant professor (or equivalent) or

new investigators:

• independent investigators at or above the level of assistant professor (or equivalent) with no more than  3 years from the start of their  faculty position
• pre-application submission is required; application submission is by invitation only.
• supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the ms research field.
• preliminary data not required.
• clinical trials not allowed.
• new investigator option supports applicants early in their faculty appointments.
  • anticipated that budgets will not exceed $150,000 in direct costs (plus indirect costs).
  • period of performance not to exceed 2 years.

investigator-initiated research award – preproposal due june 17, 2020

independent investigators at or above the level of assistant professor (or equivalent)

• pre-application submission is required; application submission is by invitation only.
• supports highly rigorous, high-impact research with the potential to make an important contribution to ms research and/or patient care.
• preliminary data required.
• clinical trials not allowed.
• anticipated that budgets will not exceed $600,000 in direct costs (plus indirect costs).
• period of performance not to exceed 3 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the msrp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org